Lawmakers Review FDA’s Investigation Of J&J Stent

Law360, New York (August 14, 2007, 12:00 AM EDT) -- Two U.S. lawmakers have asked Johnson & Johnson for records relating to a 2004 warning letter it received from the U.S. Food and Drug Administration concerning its Cypher stent as it probes the agency's handling of the matter.

U.S. Rep. John Dingell (D-Mich.), chair of the House Committee on Energy and Commerce, and U.S. Rep. Bart Stupak (D-Mich.), chair of the Subcommittee on Oversight and Investigations, requested the records from J&J in a letter on Monday as they review how effective the FDA is in its...
To view the full article, register now.